Literature DB >> 21994102

Predicting acute ischemic stroke by measuring the degree of ocular gaze deviation (Prevost's sign) on CT.

W S Lesley1, R Rangaswamy, K H Smith, D M Watkins.   

Abstract

BACKGROUND AND AIM: Ocular gaze deviation (OGD) is a well known clinical observation (Prevost's sign) in patients with acute cerebral ischemic stroke. Although OGD has been observed on CT in acute stroke, no investigation has quantified the degree of OGD in acute stroke.
MATERIAL AND METHODS: A blinded prospective comparison was performed of two groups of adult patients who underwent CT of the brain. Group 1 comprised patients with acute hemiplegia or hemiparesis due to middle cerebral artery ischemic stroke. Group 2 included ambulatory outpatients with a history of headache but no clinical neurologic signs or cerebral pathology on CT. The CT images were cropped to only show the orbital contents. A neuroradiologist, who was blinded to the clinical data, then measured the OGD for both groups. The OGD was quantified using the axial planes of the lenses relative to the nasal midline structures, and the bilateral OGD average was calculated. Both groups were also evaluated for conjugate or disconjugate gaze.
RESULTS: were analyzed using Fisher's exact test.
RESULTS: 10 of 70 patients in group 1 and 15 of 46 patients in group 2 were eligible for analysis. The frequency of conjugate and disconjugate gaze was similar in the two groups (p = 0.596). An averaged OGD of >14° and an OGD >18° in either globe was predictive of the presence of acute stroke (p = 0.0166).
CONCLUSION: Measurement of OGD is useful in predicting the presence of acute ischemic stroke.

Entities:  

Mesh:

Year:  2009        PMID: 21994102     DOI: 10.1136/jnis.2009.000281

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  7 in total

1.  Conjugate Eye Deviation on CT Associated With Worse Outcomes Despite IV Thrombolysis.

Authors:  Nirav H Shah; Nirav Bhatt; Anita Tipirneni; Diego Condes; Priyank Khandelwal; Jose G Romano
Journal:  Neurohospitalist       Date:  2016-10-24

2.  The "DeyeCOM Sign": Predictive Value in Acute Stroke Code Evaluations.

Authors:  Clarity R Coffman; Rema Raman; Karin Ernstrom; Nabeel A Herial; Konrad H Schlick; Karen Rapp; Royya F Modir; Dawn M Meyer; Thomas M Hemmen; Brett C Meyer
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-04-16       Impact factor: 2.136

3.  Frequency of eye deviation in stroke and non-stroke patients undergoing head CT.

Authors:  Kara M Schwartz; Ahmed T Ahmed; Jennifer E Fugate; Felix E Diehn; Laurence J Eckel; Christopher H Hunt; David F Kallmes
Journal:  Neurocrit Care       Date:  2012-08       Impact factor: 3.210

Review 4.  Does radiological conjugate eye deviation sign play a role in acute stroke imaging? A meta-analysis.

Authors:  Mengxue Li; Wenzhao Liang; Peng Yue; Xinzhao Jiang; Zhongyu Zhao; Bingyang Zhao; Zhongxin Xu; Jing Mang
Journal:  J Neurol       Date:  2021-04-11       Impact factor: 4.849

5.  Ocular lateral deviation with brief removal of visual fixation differentiates central from peripheral vestibular syndrome.

Authors:  Jorge C Kattah; Shervin Badihian; John H Pula; Alexander A Tarnutzer; David E Newman-Toker; David S Zee
Journal:  J Neurol       Date:  2020-07-28       Impact factor: 6.682

6.  Measurement of horizontal ocular deviation on magnetic resonance imaging in various disease with acute vertigo.

Authors:  Yeon-Jun Yang; Ji Eun Choi; Min Tae Kim; Sang Hyub Kim; Min Young Lee; Dong Soo Yoo; Jae Yun Jung
Journal:  PLoS One       Date:  2019-10-31       Impact factor: 3.240

7.  Bringing prevost's sign into the third dimension: Artificial intelligence estimation of conjugate gaze adjusted length (CGAL) and correlation with acute ischemic stroke.

Authors:  Hillel S Maresky; Joseph M Rootman; Miriam M Klar; Max Levitt; Alexander P Kossar; David Zucker; Michael Glazier; Shani Kalmanovich-Avnery; Richard Aviv; Birgit Ertl-Wagner; Sigal Tal
Journal:  Medicine (Baltimore)       Date:  2020-12-04       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.